Davita Stock Price, News & Analysis (NYSE:DVA)

$69.51 1.80 (2.66 %)
(As of 12/12/2017 04:00 PM ET)
Previous Close$67.71
Today's Range$68.21 - $69.55
52-Week Range$52.51 - $70.16
Volume2.45 million shs
Average Volume1.66 million shs
Market Capitalization$12.81 billion
P/E Ratio19.35
Dividend YieldN/A
Beta0.97

About Davita (NYSE:DVA)

Davita logoDaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.

Receive DVA News and Ratings via Email

Sign-up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Healthcare Facilities & Services
Sub-IndustryHealth Care Services
SectorMedical
SymbolNYSE:DVA
CUSIP23918K10
Phone303-405-2100

Debt

Debt-to-Equity Ratio1.79%
Current Ratio1.40%
Quick Ratio1.35%

Price-To-Earnings

Trailing P/E Ratio19.35
Forward P/E Ratio20.32
P/E Growth13.65

Sales & Book Value

Annual Sales$14.75 billion
Price / Sales0.89
Cash Flow$7.71 per share
Price / Cash9.01
Book Value$24.16 per share
Price / Book2.88

Profitability

Trailing EPS$2.60
Net Income$879.87 million
Net Margins3.40%
Return on Equity13.31%
Return on Assets3.55%

Miscellaneous

Employees70,300
Outstanding Shares189,230,000

Davita (NYSE:DVA) Frequently Asked Questions

What is Davita's stock symbol?

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

How will Davita's stock buyback program work?

Davita declared that its Board of Directors has authorized a stock buyback program on Wednesday, October 11th 2017, which authorizes the company to buyback $1,500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Stock buyback programs are often an indication that the company's board of directors believes its stock is undervalued.

How were Davita's earnings last quarter?

Davita Inc (NYSE:DVA) announced its quarterly earnings data on Tuesday, November, 7th. The company reported $0.81 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.94 by $0.13. The firm had revenue of $3.92 billion for the quarter, compared to analyst estimates of $3.91 billion. Davita had a return on equity of 13.31% and a net margin of 3.40%. The company's quarterly revenue was up 5.2% on a year-over-year basis. During the same quarter last year, the company posted $0.95 earnings per share. View Davita's Earnings History.

When will Davita make its next earnings announcement?

Davita is scheduled to release their next quarterly earnings announcement on Thursday, February, 15th 2018. View Earnings Estimates for Davita.

Where is Davita's stock going? Where will Davita's stock price be in 2017?

11 equities research analysts have issued 1-year price objectives for Davita's shares. Their forecasts range from $60.00 to $84.00. On average, they expect Davita's share price to reach $73.33 in the next year. View Analyst Ratings for Davita.

Who are some of Davita's key competitors?

Who are Davita's key executives?

Davita's management team includes the folowing people:

  • Kent J. Thiry, Chairman of the Board (Age 61)
  • James K. Hilger, Interim Chief Financial Officer, Chief Accounting Officer (Age 55)
  • Joel Ackerman, Chief Financial Officer (Age 51)
  • Robert Lang, President, International Business
  • Javier J. Rodriguez, Chief Executive Officer - Kidney Care (Age 46)
  • Jeanine M. Jiganti, Chief Compliance Officer (Age 57)
  • LeAnne M. Zumwalt, Group Vice President - purchasing and government affairs (Age 58)
  • Michael D. Staffieri, Chief Operating Officer- Kidney Care (Age 42)
  • Kathleen Alyce Waters, Chief Legal Officer (Age 49)
  • Peter T. Grauer, Lead Director, Independent Director (Age 71)

Who owns Davita stock?

Davita's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include California Public Employees Retirement System (0.26%), Canada Pension Plan Investment Board (0.23%), Schroder Investment Management Group (0.23%), Speece Thorson Capital Group Inc. (0.17%), Rhumbline Advisers (0.17%) and Hikari Power Ltd (0.16%). Company insiders that own Davita stock include Charles Berg, Christopher James Schnarr, Dennis Kogod, James K Hilger, Javier Rodriguez, Jeanine Marie Jiganti, John M Nehra, Kent J Thiry, Laura Mildenberger, Leanne M Zumwalt, Michael David Staffieri, Pamela M Arway, Roger Valine and William L Roper. View Institutional Ownership Trends for Davita.

Who sold Davita stock? Who is selling Davita stock?

Davita's stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Aperio Group LLC, Public Employees Retirement Association of Colorado, SG Americas Securities LLC and Whittier Trust Co.. Company insiders that have sold Davita company stock in the last year include Charles Berg, James K Hilger, Javier Rodriguez and William L Roper. View Insider Buying and Selling for Davita.

Who bought Davita stock? Who is buying Davita stock?

Davita's stock was acquired by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, Canada Pension Plan Investment Board, Speece Thorson Capital Group Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Hikari Power Ltd, Accident Compensation Corp, Rhumbline Advisers and FDx Advisors Inc.. View Insider Buying and Selling for Davita.

How do I buy Davita stock?

Shares of Davita can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Davita's stock price today?

One share of Davita stock can currently be purchased for approximately $69.51.

How big of a company is Davita?

Davita has a market capitalization of $12.81 billion and generates $14.75 billion in revenue each year. The company earns $879.87 million in net income (profit) each year or $2.60 on an earnings per share basis. Davita employs 70,300 workers across the globe.

How can I contact Davita?

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 303-405-2100 or via email at [email protected]


MarketBeat Community Rating for Davita (DVA)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  297 (Vote Outperform)
Underperform Votes:  315 (Vote Underperform)
Total Votes:  612
MarketBeat's community ratings are surveys of what our community members think about Davita and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Davita (NYSE:DVA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldHoldHold
Consensus Rating Score: 2.582.082.092.29
Ratings Breakdown: 1 Sell Rating(s)
5 Hold Rating(s)
4 Buy Rating(s)
2 Strong Buy Rating(s)
2 Sell Rating(s)
7 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $73.33$66.56$69.80$71.00
Price Target Upside: 5.50% upside21.01% upside21.56% upside9.65% upside

Davita (NYSE:DVA) Consensus Price Target History

Price Target History for Davita (NYSE:DVA)

Davita (NYSE:DVA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/12/2017Robert W. BairdUpgradeNeutral -> Outperform$63.00 -> $82.00LowView Rating Details
12/11/2017CitigroupUpgradeNeutral -> Buy$67.71 -> $82.00MediumView Rating Details
12/7/2017J P Morgan Chase & CoBoost Price TargetOutperform -> Strong-Buy$4.90 -> $84.00LowView Rating Details
12/7/2017SunTrust BanksSet Price TargetSell -> Hold$70.00HighView Rating Details
12/7/2017Raymond James FinancialUpgradeOutperform -> Strong-Buy$65.00 -> $84.00HighView Rating Details
12/6/2017KeyCorpReiterated RatingHoldLowView Rating Details
11/8/2017Bank of AmericaLower Price TargetNeutral$75.00 -> $66.00N/AView Rating Details
11/8/2017Royal Bank of CanadaLower Price TargetSector Perform$64.00 -> $60.00N/AView Rating Details
10/23/2017Wolfe ResearchUpgradeMarket Perform -> OutperformN/AView Rating Details
8/3/2017Jefferies GroupReiterated RatingHold$70.00MediumView Rating Details
5/25/2017Goldman Sachs GroupReiterated RatingSell$62.00HighView Rating Details
11/1/2016Wells Fargo & CompanyReiterated RatingOutperformN/AView Rating Details
4/6/2016Susquehanna BancsharesBoost Price TargetNeutral$70.00 -> $78.00N/AView Rating Details
3/2/2016Sanford C. BernsteinLower Price TargetMarket Perform$74.50 -> $71.00N/AView Rating Details
2/12/2016William BlairReiterated RatingBuyN/AView Rating Details
2/12/2016Piper Jaffray CompaniesReiterated RatingOverweight$90.00 -> $85.00N/AView Rating Details
(Data available from 12/12/2015 forward)

Earnings

Davita (NYSE:DVA) Earnings History and Estimates Chart

Earnings by Quarter for Davita (NYSE:DVA)

Davita (NYSE DVA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/14/2018$0.92N/AView Earnings Details
11/7/2017Q3 2017$0.94$0.81$3.91 billion$3.92 billionViewN/AView Earnings Details
8/1/2017Q2 2017$0.90$0.92$3.82 billion$3.88 billionViewListenView Earnings Details
5/2/2017Q1 2017$0.82$0.79$3.69 billion$3.70 billionViewListenView Earnings Details
2/16/2017Q4 2016$0.91$0.98$3.74 billion$3.72 billionViewListenView Earnings Details
11/2/2016Q316$0.94$0.95$3.72 billion$3.73 billionViewListenView Earnings Details
8/8/2016Q216$0.98$1.01$3.67 billion$3.72 billionViewListenView Earnings Details
5/4/2016Q116$0.86$0.92$3.51 billion$3.58 billionViewListenView Earnings Details
2/11/2016Q415$0.97$1.01$3.50 billion$3.53 billionViewListenView Earnings Details
11/3/2015Q315$0.97$1.00$3.46 billion$3.53 billionViewListenView Earnings Details
8/4/2015Q215$0.95$0.95$3.37 billion$3.43 billionViewListenView Earnings Details
5/4/2015Q115$0.86$0.86$3.25 billion$3.29 billionViewListenView Earnings Details
2/12/2015Q414$0.89$0.96$3.26 billion$3.33 billionViewListenView Earnings Details
11/6/2014Q314$0.91$0.90$3.19 billion$3.25 billionViewListenView Earnings Details
7/31/2014Q214$0.88$0.95$3.10 billion$3.17 billionViewListenView Earnings Details
5/1/2014Q1$0.87$0.85$3.02 billion$3.04 billionViewListenView Earnings Details
2/11/2014Q413$1.91$0.99$2.92 billion$3.06 billionViewListenView Earnings Details
11/5/2013Q313$0.96$0.98$2.93 billion$3.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$1.84$1.84$2.88 billion$2.87 billionViewListenView Earnings Details
5/7/2013Q1 2013$1.80$1.84$2.78 billion$2.83 billionViewListenView Earnings Details
2/14/2013Q4 2012$1.60$1.85$2.40 billion$2.48 billionViewListenView Earnings Details
10/30/2012$1.55$1.56ViewN/AView Earnings Details
8/1/2012$1.47$1.49ViewN/AView Earnings Details
2/16/2012$1.49$1.58ViewN/AView Earnings Details
11/3/2011$1.46$1.45ViewN/AView Earnings Details
8/3/2011$1.14$1.17ViewN/AView Earnings Details
5/2/2011$0.95$0.96ViewN/AView Earnings Details
2/10/2011$1.12$0.70ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Davita (NYSE:DVA) Earnings Estimates

2017 EPS Consensus Estimate: $3.54
2018 EPS Consensus Estimate: $3.59
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.77$0.84$0.81
Q2 20173$0.90$0.92$0.91
Q3 20173$0.90$0.95$0.93
Q4 20173$0.89$0.90$0.89
Q1 20182$0.77$0.80$0.79
Q2 20182$0.94$0.94$0.94
Q3 20182$0.95$0.95$0.95
Q4 20182$0.90$0.92$0.91
Q1 20191$0.85$0.85$0.85
Q2 20191$1.05$1.05$1.05
Q3 20191$1.04$1.04$1.04
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Davita (NYSE:DVA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Davita (NYSE DVA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.00%
Institutional Ownership Percentage: 85.32%
Insider Trades by Quarter for Davita (NYSE:DVA)
Institutional Ownership by Quarter for Davita (NYSE:DVA)

Davita (NYSE DVA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/7/2017James K HilgerInsiderSell5,608$69.46$389,531.68View SEC Filing  
12/7/2017Javier RodriguezCEOSell22,532$67.48$1,520,459.36View SEC Filing  
5/15/2017Javier RodriguezCEOSell1,294$66.21$85,675.74View SEC Filing  
5/9/2017Charles BergDirectorSell8,414$65.80$553,641.20View SEC Filing  
5/4/2017William L RoperDirectorSell12,994$65.89$856,174.66View SEC Filing  
8/9/2016Michael David StaffieriCOOSell20,262$73.09$1,480,949.58View SEC Filing  
7/11/2016Jeanine Marie JigantiInsiderSell1,291$78.51$101,356.41View SEC Filing  
7/1/2016Jeanine Marie JigantiInsiderSell4,620$77.45$357,819.00View SEC Filing  
5/25/2016Pamela M ArwayDirectorSell10,824$77.16$835,179.84View SEC Filing  
5/23/2016James K HilgerCFOSell3,416$76.79$262,314.64View SEC Filing  
5/20/2016Kent J ThiryCEOSell32,880$76.99$2,531,431.20View SEC Filing  
5/17/2016Dennis KogodCEOSell17,700$77.35$1,369,095.00View SEC Filing  
5/17/2016Leanne M ZumwaltVPSell538$77.08$41,469.04View SEC Filing  
5/16/2016James K HilgerCFOSell3,983$75.59$301,074.97View SEC Filing  
5/16/2016Javier RodriguezCEOSell36,466$75.44$2,750,995.04View SEC Filing  
5/16/2016Michael David StaffieriCOOSell4,934$75.69$373,454.46View SEC Filing  
5/12/2016Roger ValineDirectorSell8,220$76.34$627,514.80View SEC Filing  
5/10/2016Dennis KogodCEOSell40,048$76.25$3,053,660.00View SEC Filing  
5/6/2016John M NehraDirectorSell16,314$75.56$1,232,685.84View SEC Filing  
4/11/2016Javier RodriguezCEOSell89,912$73.51$6,609,431.12View SEC Filing  
3/21/2016Dennis KogodCEOSell13,455$72.12$970,374.60View SEC Filing  
2/29/2016Pamela M ArwayDirectorSell9,026$66.00$595,716.00View SEC Filing  
2/23/2016Leanne M. ZumwaltVPSell14,587$64.25$937,214.75View SEC Filing  
2/16/2016Dennis KogodCEOSell33,290$61.99$2,063,647.10View SEC Filing  
1/13/2016Christopher James SchnarrInsiderBuy5,000$0.68$3,400.00
1/11/2016Christopher James SchnarrInsiderBuy10,000$0.60$6,000.00
12/17/2015Laura MildenbergerinsiderSell1,440$68.14$98,121.60View SEC Filing  
9/22/2015Kim M. RiverainsiderSell40,037$75.48$3,021,992.76View SEC Filing  
8/17/2015Carol Anthony DavidsonDirectorSell4,038$79.93$322,757.34View SEC Filing  
6/4/2015Robert J MargolisChairmanSell31,400$83.39$2,618,446.00View SEC Filing  
5/28/2015Michael David StaffieriCOOSell9,050$84.07$760,833.50View SEC Filing  
5/19/2015Robert J MargolisChairmanSell15,700$83.22$1,306,554.00View SEC Filing  
5/18/2015James K HilgerCFOSell3,983$82.10$327,004.30View SEC Filing  
5/18/2015Michael David StaffieriCOOSell2,047$82.03$167,915.41View SEC Filing  
5/18/2015Robert J MargolisChairmanSell15,700$82.24$1,291,168.00View SEC Filing  
5/11/2015James K HilgerCFOSell8,267$82.00$677,894.00View SEC Filing  
5/11/2015Jeanine Marie JigantiInsiderSell2,481$81.95$203,317.95View SEC Filing  
5/11/2015John M NehraDirectorSell12,278$81.85$1,004,954.30View SEC Filing  
4/21/2015Robert J MargolisChairmanSell31,400$82.40$2,587,360.00View SEC Filing  
4/7/2015Robert J MargolisChairmanSell15,700$82.15$1,289,755.00View SEC Filing  
4/6/2015Robert J MargolisChairmanSell15,700$81.49$1,279,393.00View SEC Filing  
3/27/2015Robert J MargolisChairmanSell31,400$81.18$2,549,052.00View SEC Filing  
3/12/2015Robert J MargolisChairmanSell107,374$79.24$8,508,315.76View SEC Filing  
2/27/2015Robert J MargolisChairmanSell21,000$74.29$1,560,090.00View SEC Filing  
2/19/2015Robert J MargolisChairmanSell21,000$73.12$1,535,520.00View SEC Filing  
1/30/2015Robert J MargolisChairmanSell31,400$75.48$2,370,072.00View SEC Filing  
1/23/2015Michael David StaffieriCOOSell21,869$76.05$1,663,137.45View SEC Filing  
1/16/2015Robert J MargolisChairmanSell31,400$74.92$2,352,488.00View SEC Filing  
1/8/2015Kim M RiveraInsiderSell1,111$75.10$83,436.10View SEC Filing  
12/30/2014Robert J MargolisChairmanSell31,400$76.09$2,389,226.00View SEC Filing  
12/29/2014Robert J MargolisChairmanSell15,700$76.09$1,194,613.00View SEC Filing  
12/19/2014Laura MildenbergerInsiderSell1,446$75.50$109,173.00View SEC Filing  
12/18/2014Robert J MargolisChairmanSell31,400$74.67$2,344,638.00View SEC Filing  
12/3/2014Robert J MargolisChairmanSell31,400$75.80$2,380,120.00View SEC Filing  
12/1/2014Kim M RiveraInsiderSell6,503$76.08$494,748.24View SEC Filing  
11/21/2014Robert J MargolisChairmanSell31,400$75.08$2,357,512.00View SEC Filing  
11/11/2014Kent J ThiryCEOSell344,938$74.52$25,704,779.76View SEC Filing  
11/11/2014Robert J MargolisChairmanSell250,000$75.09$18,772,500.00View SEC Filing  
11/10/2014Berkshire Hathaway IncMajor ShareholderBuy944,418$74.11$69,990,817.98View SEC Filing  
11/7/2014R. Ted WeschlerMajor ShareholderBuy820,018$74.10$60,763,333.80View SEC Filing  
11/3/2014Roger ValineDirectorSell7,185$77.85$559,352.25View SEC Filing  
9/16/2014John M NehraDirectorSell20,000$73.91$1,478,200.00View SEC Filing  
9/8/2014Kim M RiveraInsiderSell1,111$74.25$82,491.75View SEC Filing  
8/27/2014Leanne M ZumwaltVPSell3,214$74.57$239,667.98View SEC Filing  
8/11/2014Jeanine Marie JigantiInsiderSell2,500$72.14$180,350.00View SEC Filing  
6/11/2014Kim M RiveraInsiderSell5,929$71.05$421,255.45View SEC Filing  
5/29/2014Laura MildenbergerInsiderSell5,080$69.99$355,549.20View SEC Filing  
5/16/2014Dennis KogodCOOSell18,750$67.30$1,261,875.00View SEC Filing  
5/16/2014Kent ThiryCEOSell17,600$67.41$1,186,416.00View SEC Filing  
5/15/2014James HilgerCAOSell1,666$67.23$112,005.18View SEC Filing  
5/15/2014Javier RodriguezCEOSell7,000$67.50$472,500.00View SEC Filing  
5/12/2014Dennis KogodCOOSell32,188$68.06$2,190,715.28View SEC Filing  
5/8/2014Dennis KogodCOOSell32,213$67.36$2,169,867.68View SEC Filing  
5/7/2014Michael David StaffieriCOOSell2,633$67.30$177,200.90View SEC Filing  
4/2/2014Michael David StaffieriCOOSell2,867$69.15$198,253.05View SEC Filing  
3/20/2014Laura MildenbergerInsiderSell3,274$70.04$229,310.96View SEC Filing  
2/26/2014R. Ted Weschlermajor shareholderBuy1,159,858$66.97$77,675,690.26View SEC Filing  
2/21/2014John NehraDirectorSell40,000$65.81$2,632,400.00View SEC Filing  
2/18/2014William RoperDirectorSell42,519$66.37$2,821,986.03View SEC Filing  
12/20/2013Laura MildenbergerInsiderSell10,417$62.53$651,375.01View SEC Filing  
12/17/2013Allen NissensonInsiderSell2,929$59.83$175,242.07View SEC Filing  
12/9/2013Berkshire Hathaway Incmajor shareholderBuy1,314,170$57.84$76,011,592.80View SEC Filing  
11/8/2013R. Ted Weschlermajor shareholderBuy3,700,294$55.14$204,034,211.16View SEC Filing  
7/5/2013Berkshire Hathaway IncMajor ShareholderBuy110,309$114.01$12,576,329.09View SEC Filing  
7/3/2013R. Ted WeschlerMajor ShareholderBuy639,200$114.78$73,367,376.00View SEC Filing  
5/15/2013David T ShapiroInsiderSell8,779$129.80$1,139,514.20View SEC Filing  
5/15/2013Dennis KogodCOOSell21,130$129.47$2,735,701.10View SEC Filing  
5/15/2013James K HilgerCFOSell1,049$130.18$136,558.82View SEC Filing  
5/15/2013Leanne M ZumwaltVPSell13,209$129.59$1,711,754.31View SEC Filing  
5/13/2013Kent J ThiryCEOSell243,307$129.95$31,617,744.65View SEC Filing  
5/13/2013Kim M RiveraInsiderSell1,672$129.70$216,858.40View SEC Filing  
3/4/2013Berkshire Hathaway IncMajor ShareholderBuy164,947$119.59$19,726,011.73View SEC Filing  
3/4/2013Roger ValineDirectorSell1,390$120.00$166,800.00View SEC Filing  
2/27/2013Berkshire Hathaway IncMajor ShareholderBuy211,889$116.56$24,697,781.84View SEC Filing  
2/22/2013Berkshire Hathaway IncMajor ShareholderBuy224,091$115.88$25,967,665.08View SEC Filing  
2/19/2013Berkshire Hathaway IncMajor ShareholderBuy323,070$116.73$37,711,961.10View SEC Filing  
2/5/2013Berkshire Hathaway IncMajor ShareholderBuy32,376$115.17$3,728,743.92View SEC Filing  
2/4/2013Roger ValineDirectorSell1,389$116.13$161,304.57View SEC Filing  
1/16/2013Berkshire Hathaway IncMajor ShareholderBuy42,400$111.33$4,720,392.00View SEC Filing  
1/15/2013Berkshire Hathaway IncMajor ShareholderBuy179,300$109.67$19,663,831.00View SEC Filing  
1/10/2013Berkshire Hathaway IncMajor ShareholderBuy187,898$109.54$20,582,346.92View SEC Filing  
12/24/2012Dennis KogodCOOSell12,736$111.00$1,413,696.00View SEC Filing  
12/21/2012James K HilgerCFOSell2,073$112.20$232,590.60View SEC Filing  
12/6/2012Berkshire Hathaway IncMajor ShareholderBuy635,633$106.20$67,504,224.60View SEC Filing  
11/29/2012Berkshire Hathaway IncMajor ShareholderBuy679,249$108.20$73,494,741.80View SEC Filing  
11/26/2012Berkshire Hathaway IncMajor ShareholderBuy412,050$110.38$45,482,079.00View SEC Filing  
11/16/2012Berkshire Hathaway IncMajor ShareholderBuy132,958$112.45$14,951,127.10View SEC Filing  
11/12/2012Berkshire Hathaway IncMajor ShareholderBuy548,823$112.15$61,550,499.45View SEC Filing  
11/7/2012Berkshire Hathaway IncMajor ShareholderBuy139,491$112.03$15,627,176.73View SEC Filing  
11/2/2012Berkshire Hathaway IncMajor ShareholderBuy254,750$112.20$28,582,950.00View SEC Filing  
10/26/2012Berkshire Hathaway IncMajor ShareholderBuy257,941$111.14$28,667,562.74View SEC Filing  
10/17/2012Berkshire Hathaway IncMajor ShareholderBuy63,928$109.56$7,003,951.68View SEC Filing  
10/12/2012Berkshire Hathaway IncMajor ShareholderBuy217,597$109.76$23,883,446.72View SEC Filing  
10/9/2012Berkshire Hathaway IncMajor ShareholderBuy67,946$107.71$7,318,463.66View SEC Filing  
9/28/2012Berkshire Hathaway IncMajor ShareholderBuy282,403$102.03$28,813,578.09View SEC Filing  
8/8/2012Kent J ThiryChairmanSell320,877$96.88$31,086,563.76View SEC Filing  
8/7/2012William L RoperDirectorSell23,019$95.95$2,208,673.05View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Davita (NYSE DVA) News Headlines

Source:
DateHeadline
Davita (DVA) Upgraded to "Outperform" at Robert W. BairdDavita (DVA) Upgraded to "Outperform" at Robert W. Baird
www.americanbankingnews.com - December 12 at 9:04 AM
Davita (DVA) Upgraded to "Buy" by CitigroupDavita (DVA) Upgraded to "Buy" by Citigroup
www.americanbankingnews.com - December 11 at 10:48 PM
Insider Selling: Davita Inc (DVA) Insider Sells 5,608 Shares of StockInsider Selling: Davita Inc (DVA) Insider Sells 5,608 Shares of Stock
www.americanbankingnews.com - December 11 at 8:53 PM
Javier Rodriguez Sells 22,532 Shares of Davita Inc (DVA) StockJavier Rodriguez Sells 22,532 Shares of Davita Inc (DVA) Stock
www.americanbankingnews.com - December 11 at 8:50 PM
Davita Inc Expected to Post FY2019 Earnings of $3.92 Per Share (DVA)Davita Inc Expected to Post FY2019 Earnings of $3.92 Per Share (DVA)
www.americanbankingnews.com - December 11 at 3:00 PM
Citi Upgrades DaVita (DVA) to Buy - StreetInsider.comCiti Upgrades DaVita (DVA) to Buy - StreetInsider.com
www.streetinsider.com - December 11 at 10:26 AM
FY2018 Earnings Estimate for DaVita HealthCare Partners Inc. Issued By KeyCorp (DVA)FY2018 Earnings Estimate for DaVita HealthCare Partners Inc. Issued By KeyCorp (DVA)
www.americanbankingnews.com - December 8 at 12:58 PM
Dow 30 Stock Roundup: UnitedHealth to Buy DaVita Unit for $4.9B, Chevron to Cut CapEx in 2018Dow 30 Stock Roundup: UnitedHealth to Buy DaVita Unit for $4.9B, Chevron to Cut CapEx in 2018
finance.yahoo.com - December 8 at 9:41 AM
UnitedHealth on A.M.Best's Radar After Buyout AnnouncementUnitedHealth on A.M.Best's Radar After Buyout Announcement
finance.yahoo.com - December 8 at 9:41 AM
DaVita HealthCare Partners Inc. (DVA) Receives Consensus Recommendation of "Hold" from AnalystsDaVita HealthCare Partners Inc. (DVA) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - December 8 at 2:26 AM
DaVita HealthCare Partners (DVA) PT Raised to $84.00 at J P Morgan Chase & CoDaVita HealthCare Partners (DVA) PT Raised to $84.00 at J P Morgan Chase & Co
www.americanbankingnews.com - December 7 at 3:38 PM
DaVita HealthCare Partners (DVA) Price Target Raised to $70.00DaVita HealthCare Partners (DVA) Price Target Raised to $70.00
www.americanbankingnews.com - December 7 at 10:04 AM
DaVita HealthCare Partners (DVA) Rating Increased to Strong-Buy at Raymond James FinancialDaVita HealthCare Partners (DVA) Rating Increased to Strong-Buy at Raymond James Financial
www.americanbankingnews.com - December 7 at 9:14 AM
Recent DVA NewsRecent DVA News
www.bloomberg.com - December 6 at 5:11 PM
DaVita Medical Group to be sold for $4.9 billionDaVita Medical Group to be sold for $4.9 billion
www.bizjournals.com - December 6 at 5:11 PM
Warren Buffett scores a quick $230 million with DaVita de...Warren Buffett scores a quick $230 million with DaVita de...
finance.yahoo.com - December 6 at 5:11 PM
Aetna CEO to Receive $500 Million Once CVS Deal Closes: MARKETS LIVEAetna CEO to Receive $500 Million Once CVS Deal Closes: MARKETS LIVE
finance.yahoo.com - December 6 at 5:11 PM
3 Stocks Jump on Wednesday3 Stocks Jump on Wednesday
finance.yahoo.com - December 6 at 5:11 PM
DaVita and AeroVironment jump while Freds and Patterson dipDaVita and AeroVironment jump while Fred's and Patterson dip
finance.yahoo.com - December 6 at 5:11 PM
DaVita HealthCare Partners (DVA) Stock Rating Reaffirmed by KeyCorpDaVita HealthCare Partners (DVA) Stock Rating Reaffirmed by KeyCorp
www.americanbankingnews.com - December 6 at 3:36 PM
Why DaVita Inc. Jumped Higher TodayWhy DaVita Inc. Jumped Higher Today
www.fool.com - December 6 at 1:34 PM
DaVita HealthCare Partners (DVA) Is Up Sharply After UnitedHealth DealDaVita HealthCare Partners (DVA) Is Up Sharply After UnitedHealth Deal
www.rttnews.com - December 6 at 9:52 AM
New Strong Sell Stocks for December 6thNew Strong Sell Stocks for December 6th
finance.yahoo.com - December 6 at 9:52 AM
Morning Movers: DaVita, Bitcoin Soar; Home Depot, Snap SlumpMorning Movers: DaVita, Bitcoin Soar; Home Depot, Snap Slump
finance.yahoo.com - December 6 at 9:52 AM
UnitedHealth Buys DaVita's Medical Unit Amid Big Sector ShakeupUnitedHealth Buys DaVita's Medical Unit Amid Big Sector Shakeup
finance.yahoo.com - December 6 at 9:52 AM
UnitedHealth to Buy Physician Group for $4.9 Billion: LIVE MARKETS BLOGUnitedHealth to Buy Physician Group for $4.9 Billion: LIVE MARKETS BLOG
finance.yahoo.com - December 6 at 9:52 AM
DaVita HealthCare Partners (DVA) versus Mednax (MD) Critical ReviewDaVita HealthCare Partners (DVA) versus Mednax (MD) Critical Review
www.americanbankingnews.com - December 4 at 11:26 PM
DaVita Joins Mayor Hancocks Sustainable Denver Summit as Presenting SponsorDaVita Joins Mayor Hancock's Sustainable Denver Summit as Presenting Sponsor
finance.yahoo.com - December 4 at 5:09 PM
DaVita HealthCare Partners Target of Unusually Large Options Trading (DVA)DaVita HealthCare Partners Target of Unusually Large Options Trading (DVA)
www.americanbankingnews.com - December 4 at 4:04 AM
3 of Warren Buffett's Favorite Healthcare Stocks That You Can Buy Right Now3 of Warren Buffett's Favorite Healthcare Stocks That You Can Buy Right Now
finance.yahoo.com - December 3 at 9:45 AM
$3.89 Billion in Sales Expected for DaVita HealthCare Partners Inc. (DVA) This Quarter$3.89 Billion in Sales Expected for DaVita HealthCare Partners Inc. (DVA) This Quarter
www.americanbankingnews.com - November 29 at 4:32 AM
DaVita: Preparing for an Estate Sale?DaVita: Preparing for an Estate Sale?
finance.yahoo.com - November 28 at 5:09 PM
DaVita acquires major Northwest physicians groupDaVita acquires major Northwest physicians group
finance.yahoo.com - November 28 at 5:09 PM
DaVita, Inc. breached its 50 day moving average in a Bullish Manner : DVA-US : November 28, 2017DaVita, Inc. breached its 50 day moving average in a Bullish Manner : DVA-US : November 28, 2017
finance.yahoo.com - November 28 at 8:46 AM
$0.91 Earnings Per Share Expected for DaVita HealthCare Partners Inc. (DVA) This Quarter$0.91 Earnings Per Share Expected for DaVita HealthCare Partners Inc. (DVA) This Quarter
www.americanbankingnews.com - November 27 at 5:20 PM
DaVita HealthCare Partners Inc. (DVA) Stock Rating Reaffirmed by KeyCorpDaVita HealthCare Partners Inc. (DVA) Stock Rating Reaffirmed by KeyCorp
www.americanbankingnews.com - November 25 at 4:52 PM
The Hot Stock: DaVita Climbs 3.2%The Hot Stock: DaVita Climbs 3.2%
finance.yahoo.com - November 24 at 4:13 PM
DaVita IncDaVita Inc
www.bloomberg.com - November 24 at 10:49 AM
Exclusive: DaVita explores sale of physician network business - sourcesExclusive: DaVita explores sale of physician network business - sources
finance.yahoo.com - November 22 at 6:50 PM
DaVita Issues Downbeat 17 View, Hurricanes Affect Q3 Results - NasdaqDaVita Issues Downbeat '17 View, Hurricanes Affect Q3 Results - Nasdaq
www.nasdaq.com - November 16 at 1:39 PM
DaVita Issues Downbeat '17 View, Hurricanes Affect Q3 ResultsDaVita Issues Downbeat '17 View, Hurricanes Affect Q3 Results
finance.yahoo.com - November 16 at 1:39 PM
DaVita HealthCare Partners Inc. Expected to Earn FY2017 Earnings of $3.42 Per Share (DVA)DaVita HealthCare Partners Inc. Expected to Earn FY2017 Earnings of $3.42 Per Share (DVA)
www.americanbankingnews.com - November 14 at 8:44 AM
Contrasting Fresenius Medical Care Corporation (FMS) & DaVita HealthCare Partners (DVA)Contrasting Fresenius Medical Care Corporation (FMS) & DaVita HealthCare Partners (DVA)
www.americanbankingnews.com - November 13 at 11:28 AM
DaVita HealthCare Partners Inc. (DVA) Given "Hold" Rating at Robert W. BairdDaVita HealthCare Partners Inc. (DVA) Given "Hold" Rating at Robert W. Baird
www.americanbankingnews.com - November 11 at 11:12 AM
Zacks: Analysts Anticipate DaVita HealthCare Partners Inc. (DVA) Will Announce Quarterly Sales of $3.89 BillionZacks: Analysts Anticipate DaVita HealthCare Partners Inc. (DVA) Will Announce Quarterly Sales of $3.89 Billion
www.americanbankingnews.com - November 11 at 10:22 AM
DaVita, Inc. – Value Analysis (NYSE:DVA) : November 10, 2017DaVita, Inc. – Value Analysis (NYSE:DVA) : November 10, 2017
finance.yahoo.com - November 10 at 6:35 PM
DaVita Honors and Supports VeteransDaVita Honors and Supports Veterans
finance.yahoo.com - November 10 at 11:09 AM
DaVita, Inc. breached its 50 day moving average in a Bearish Manner : DVA-US : November 9, 2017DaVita, Inc. breached its 50 day moving average in a Bearish Manner : DVA-US : November 9, 2017
finance.yahoo.com - November 10 at 11:09 AM
New Strong Sell Stocks for November 10thNew Strong Sell Stocks for November 10th
finance.yahoo.com - November 10 at 11:09 AM
DaVita HealthCare Partners Inc. to Post FY2017 Earnings of $3.43 Per Share, SunTrust Banks Forecasts (DVA)DaVita HealthCare Partners Inc. to Post FY2017 Earnings of $3.43 Per Share, SunTrust Banks Forecasts (DVA)
www.americanbankingnews.com - November 9 at 7:54 AM

SEC Filings

Davita (NYSE:DVA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Davita (NYSE:DVA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Davita (NYSE DVA) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.